F S&P 500
5,436.00 -1.50 (-0.03%) F Dow Jones
38,585.00 -20.00 (-0.05%) F Nasdaq
19,702.25 +16.75 (+0.09%) E-mini Russell 2000 Index Futur
2,007.30 -0.70 (-0.03%) Petróleo
78.19 -0.26 (-0.33%) Oro
2,339.50 -9.60 (-0.41%)
Silo Wellness Inc. (3K7A.F)
Silo Wellness Inc.
200 Consumers Road
Suite 702
Toronto, ON M2J 4R4
Canada
541-900-5871
https://www.silowellness.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Mike Arnold | Founder, CEO, President & Chairman | 202.5k | N/D | N/D |
| Mr. Yongbiao Ding B.A., C.A., M.B.A. | CFO & Director | N/D | N/D | 1966 |
| Mr. Michael Hartman | COO & Director | N/D | N/D | N/D |
| Mr. Stuart Kirby | Vice President of Marketing & Communications | N/D | N/D | N/D |
Descripción
Silo Wellness Inc., a psychedelics and wellness company, develops psychedelic medicine to reduce trauma. The company develops and sells psilocybin-free functional mushroom tinctures; and the formulation of a psilocybin nasal spray in Jamaica. It also offers a portfolio of functional mushroom products: Jamaican and Oregon psychedelic wellness retreats. The company was formerly known as Yukoterre Resources Inc. and changed its name to Silo Wellness Inc. February 26, 2021. Silo Wellness Inc. is headquartered in Toronto, Canada.
Gestión corporativa
La calificación ISS Governance QuickScore de Silo Wellness Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
